AW ACTAVIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Jun 2022)
What this means for you
This application is over — abandoned 20 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87837595
- Mark type
- Design + words
- Filed
- 16 Mar 2018
- Published for opposition
- 19 Mar 2019
- Abandoned
- 20 Jun 2022
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, neurological disorders, neurodegenerative disorders, and depression, antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic, anti-inflammatory ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Owner
- ACTAVIS HOLDCO US, INC, Parsippany, NJ, US
- ACTAVIS HOLDCO US, INC, Parsippany, NJ, US
Prior registrations
Prosecution history
- 21 Jun 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Jun 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Nov 2021 — SOU EXTENSION 5 GRANTED
- 09 Nov 2021 — SOU EXTENSION 5 FILED
- 16 Nov 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 18 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2021 — SOU EXTENSION 4 GRANTED
- 14 May 2021 — SOU EXTENSION 4 FILED
- 14 May 2021 — SOU TEAS EXTENSION RECEIVED
- 07 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2020 — SOU EXTENSION 3 GRANTED
- 05 Nov 2020 — SOU EXTENSION 3 FILED
- 05 Nov 2020 — SOU TEAS EXTENSION RECEIVED